Get the Stockscreener App
6.71
7.32%
-0.53
After Hours:
6.70
-0.010
-0.15%
Nuvectis Pharma Inc Stock (NVCT) Forecast
The Nuvectis Pharma Inc (NVCT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $6.4441, representing a -3.96% decrease from the current price of $6.71. The highest analyst price target is $6.9642, and the lowest is $5.924.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NVCT Price Target
Average 12.15
(+81.01% Upside)
Is Nuvectis Pharma Inc (NVCT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 57.55 | Neutral |
| STOCH(9,6) | 61.31 | Neutral |
| STOCHRSI(14) | 26.23 | Neutral |
| MACD(12,26) | 0.3813 | Buy |
| ADX(14) | 34.03 | Buy |
| William %R | -51.81 | Neutral |
| CCI(14) | 37.88 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.788
Sell
|
6.7565
Sell
|
| MA20 |
6.312
Buy
|
6.4373
Buy
|
| MA50 |
5.574
Buy
|
6.1188
Buy
|
| MA100 |
6.2763
Buy
|
6.2224
Buy
|
| MA200 |
6.4434
Buy
|
6.6956
Buy
|
Buy: 8
Sell: 2
Neutral: 0
Summary: Buy
According to our latest analysis, NVCT could be considered a Strong Buy, with 17 technical analysis indicators signaling 10 Buy signals, 2 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on NVCT, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 57.55 indicates that NVCT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 61.31 indicates that NVCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 26.23 indicates that NVCT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 34.03 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 37.88 indicates that NVCT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term NVCT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Nuvectis Pharma Inc financial reports and earnings history, Nuvectis Pharma Inc (NVCT) stock could reach $11.39 by 2030, $18.90 by 2040 and $6.491 by 2050. See the projected annual prices until 2050 of the Nuvectis Pharma Inc stock below:
- Nuvectis Pharma Inc (NVCT) is expected to reach an average price of $10.55 in 2035, with a high prediction of $12.25 and a low estimate of $8.3595. This indicates an $57.24% rise from the last recorded price of $6.71.
- Nuvectis Pharma Inc (NVCT) stock is projected to chart a bullish course in 2040, with an average price target of $13.48, representing an $100.90% surge from its current level. The forecast ranges from a conservative $6.5483 to a sky-high $18.90.
- Our analysts predict Nuvectis Pharma Inc (NVCT) to jump -34.17% by 2045, soaring from $3.4157 to an average price of $4.4173, potentially reaching $7.1949. While $3.4157 is the low estimate, the potential upside is significant.
- Nuvectis Pharma Inc (NVCT) stock is expected to climb by 2050, reaching an average of $3.152, a $-53.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $6.491 and $2.121, respectively, highlighting the market's uncertainty.
Nuvectis Pharma Inc Stock (NVCT) Year by Year Forecast
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2025
Nuvectis Pharma Inc Stock (NVCT) is expected to reach an average price of $12.15 in 2025, with a high prediction of $18.37 and a low estimate of $5.924. This indicates an +81.01% rise from the last recorded price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $6.9422 | $5.924 | $6.9642 | +3.46% |
| April, 2025 | $7.1246 | $6.6143 | $7.8344 | +6.18% |
| May, 2025 | $7.125 | $6.8549 | $7.7048 | +6.18% |
| June, 2025 | $10.09 | $6.8552 | $10.70 | +50.38% |
| July, 2025 | $11.70 | $9.1955 | $14.80 | +74.30% |
| August, 2025 | $12.83 | $9.2706 | $13.18 | +91.15% |
| September, 2025 | $14.52 | $11.80 | $14.62 | +116.34% |
| October, 2025 | $17.22 | $12.31 | $17.54 | +156.59% |
| November, 2025 | $16.67 | $16.42 | $18.37 | +148.40% |
| December, 2025 | $13.56 | $13.05 | $16.71 | +102.05% |
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2026
The predicted value for Nuvectis Pharma Inc (NVCT) in 2026 is set at an average of $9.9742. Estimates vary from a peak of $15.22 to a trough of $4.7302, indicating an +48.65% surge from the present price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $14.65 | $12.99 | $15.16 | +118.30% |
| February, 2026 | $13.49 | $12.77 | $15.22 | +101.02% |
| March, 2026 | $11.02 | $10.31 | $14.68 | +64.22% |
| April, 2026 | $9.2793 | $7.6341 | $11.34 | +38.29% |
| May, 2026 | $8.2197 | $7.2297 | $9.6994 | +22.50% |
| June, 2026 | $8.03 | $7.22 | $8.7799 | +19.67% |
| July, 2026 | $7.3805 | $5.9205 | $10.72 | +9.99% |
| August, 2026 | $7.2409 | $6.2408 | $7.896 | +7.91% |
| September, 2026 | $10.72 | $6.2909 | $11.82 | +59.78% |
| October, 2026 | $6.7417 | $6.5717 | $11.61 | +0.47% |
| November, 2026 | $6.3764 | $5.6419 | $7.1109 | -4.97% |
| December, 2026 | $6.9507 | $4.7302 | $9.1002 | +3.59% |
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Nuvectis Pharma Inc (NVCT) is $12.89, with a high forecast of $20.34 and a low forecast of $5.4413. This indicates an +92.13% increase from the last price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $6.8314 | $5.4413 | $9.2211 | +1.81% |
| February, 2027 | $9.1022 | $6.4316 | $10.46 | +35.65% |
| March, 2027 | $15.08 | $7.9925 | $20.34 | +124.79% |
| April, 2027 | $10.39 | $9.2238 | $16.06 | +54.90% |
| May, 2027 | $12.13 | $9.624 | $13.86 | +80.84% |
| June, 2027 | $8.1354 | $7.2754 | $12.24 | +21.24% |
| July, 2027 | $7.7161 | $6.766 | $9.372 | +14.99% |
| August, 2027 | $6.5169 | $6.5169 | $8.1463 | -2.88% |
| September, 2027 | $6.2078 | $6.0672 | $7.2271 | -7.48% |
| October, 2027 | $6.6985 | $5.638 | $6.8139 | -0.17% |
| November, 2027 | $6.8392 | $6.4387 | $7.5489 | +1.93% |
| December, 2027 | $6.9301 | $6.5698 | $7.4196 | +3.28% |
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2028
In 2028, Nuvectis Pharma Inc (NVCT) is projected to reach an average price of $12.33, with a high projection of $18.08 and a low estimate of $6.5703. This indicates an +83.72% rise from the last price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $13.80 | $6.5703 | $14.21 | +105.68% |
| February, 2028 | $11.41 | $8.911 | $14.52 | +70.07% |
| March, 2028 | $12.43 | $8.9865 | $12.93 | +85.28% |
| April, 2028 | $14.48 | $11.90 | $14.68 | +115.85% |
| May, 2028 | $17.01 | $14.03 | $17.25 | +153.56% |
| June, 2028 | $15.40 | $15.34 | $18.08 | +129.58% |
| July, 2028 | $13.28 | $12.77 | $15.84 | +97.85% |
| August, 2028 | $13.79 | $12.71 | $14.94 | +105.46% |
| September, 2028 | $14.02 | $12.26 | $14.64 | +108.90% |
| October, 2028 | $8.6979 | $7.7679 | $14.40 | +29.63% |
| November, 2028 | $7.4988 | $7.3533 | $10.94 | +11.76% |
| December, 2028 | $7.8495 | $6.9494 | $8.439 | +16.98% |
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2029
The 2029 price forecast for Nuvectis Pharma Inc Stock (NVCT) is $12.25 on average, with a high prediction of $20.05 and a low estimate of $4.4403. This represents an +82.52% increase from the previous price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.6904 | $6.9401 | $9.0603 | +29.51% |
| February, 2029 | $6.7312 | $5.641 | $10.44 | +0.32% |
| March, 2029 | $6.9619 | $5.9615 | $7.6519 | +3.75% |
| April, 2029 | $10.44 | $6.8621 | $11.54 | +55.63% |
| May, 2029 | $6.2635 | $5.7435 | $11.33 | -6.65% |
| June, 2029 | $6.07 | $5.18 | $6.8328 | -9.54% |
| July, 2029 | $6.6611 | $4.4403 | $8.8103 | -0.73% |
| August, 2029 | $6.1524 | $5.1519 | $8.9316 | -8.31% |
| September, 2029 | $8.6335 | $6.1471 | $10.17 | +28.67% |
| October, 2029 | $14.16 | $8.3738 | $20.05 | +111.10% |
| November, 2029 | $10.63 | $8.9357 | $14.15 | +58.36% |
| December, 2029 | $10.43 | $9.5665 | $13.58 | +55.48% |
Nuvectis Pharma Inc Stock (NVCT) Price Forecast for 2030
Nuvectis Pharma Inc Stock (NVCT) is expected to reach an average price of $11.16 in 2030, with a high forecast of $16.97 and a low forecast of $5.3519. This signifies an +66.34% surge from the last price of $6.71.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $8.1284 | $6.9881 | $11.39 | +21.14% |
| February, 2030 | $7.5395 | $6.479 | $8.5987 | +12.36% |
| March, 2030 | $6.1506 | $6.1406 | $7.6398 | -8.34% |
| April, 2030 | $5.9217 | $5.7809 | $6.3916 | -11.75% |
| May, 2030 | $6.493 | $5.3519 | $6.613 | -3.23% |
| June, 2030 | $6.8866 | $6.3033 | $7.2633 | +2.63% |
| July, 2030 | $7.1255 | $6.2847 | $7.7978 | +6.19% |
| August, 2030 | $9.1165 | $6.8557 | $14.23 | +35.87% |
| September, 2030 | $9.9201 | $9.0468 | $11.15 | +47.84% |
| October, 2030 | $13.89 | $8.7025 | $14.05 | +106.99% |
| November, 2030 | $15.13 | $11.74 | $15.35 | +125.49% |
| December, 2030 | $16.73 | $14.67 | $16.97 | +149.35% |
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):